QIAGEN NV's ticker is QGENXXXX and the CUSIP is N72482107. A total of 164 filers reported holding QIAGEN NV in Q4 2013. The put-call ratio across all filers is 0.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $322,000 | +125.2% | 11,467 | +119.8% | 0.05% | +163.2% |
| Q3 2016 | $143,000 | +13.5% | 5,217 | -10.0% | 0.02% | +18.8% |
| Q2 2016 | $126,000 | -33.3% | 5,795 | -15.4% | 0.02% | -15.8% |
| Q4 2015 | $189,000 | +6.8% | 6,849 | 0.0% | 0.02% | +5.6% |
| Q3 2015 | $177,000 | +10.6% | 6,849 | +6.4% | 0.02% | +28.6% |
| Q2 2015 | $160,000 | -1.2% | 6,437 | 0.0% | 0.01% | +7.7% |
| Q1 2015 | $162,000 | -2.4% | 6,437 | -9.2% | 0.01% | -7.1% |
| Q4 2014 | $166,000 | -5.7% | 7,088 | -8.3% | 0.01% | 0.0% |
| Q3 2014 | $176,000 | -4.3% | 7,729 | +2.9% | 0.01% | -6.7% |
| Q2 2014 | $184,000 | +16.5% | 7,510 | 0.0% | 0.02% | +36.4% |
| Q1 2014 | $158,000 | -24.8% | 7,510 | -14.8% | 0.01% | -31.2% |
| Q4 2013 | $210,000 | +11.1% | 8,810 | 0.0% | 0.02% | +6.7% |
| Q3 2013 | $189,000 | -72.4% | 8,810 | -74.4% | 0.02% | -74.1% |
| Q2 2013 | $684,000 | – | 34,350 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Exane Asset Management | 642,752 | $14,260,214,000 | 5.53% |
| Tikvah Management LLC | 369,425 | $8,057,000 | 4.72% |
| Hardman Johnston Global Advisors LLC | 3,797,024 | $82,813,000 | 4.22% |
| HealthCor Management, L.P. | 2,500,000 | $54,525,000 | 2.97% |
| Opus Point Partners Management, LLC | 105,751 | $2,306,000 | 2.23% |
| CRAMER ROSENTHAL MCGLYNN LLC | 4,018,074 | $87,634,000 | 1.41% |
| Douglas Lane & Associates, LLC | 1,942,678 | $42,370,000 | 1.22% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,167,768 | $47,279,000 | 1.17% |
| MANNING & NAPIER ADVISORS LLC | 6,111,364 | $133,287,000 | 0.81% |
| PRIMECAP MANAGEMENT CO/CA/ | 20,128,325 | $438,999,000 | 0.47% |